This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by López-Ríos, F. Articles by Cuezva, J. M. Search for Related Content PubMed PubMed Citation Articles by López-Ríos, F. Articles by Cuezva, J. M.

Loss of the Mitochondrial Bioenergetic Capacity Underlies the Glucose Avidity of Carcinomas

¹ Hospital Universitario 12 de Octubre, CIBER de Enfermedades Respiratorias; ² Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, CIBER de Enfermedades Raras, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Cientificas; and ³ Departamento de Matemáticas, Universidad Autónoma de Madrid, Madrid, Spain

Requests for reprints: José M. Cuezva, Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, 28049 Madrid, Spain. Phone: 34-91-497-4866; Fax: 34-91-497-4799; E-mail: jmcuezva{at}cbm.uam.es.

The down-regulation of the catalytic subunit of the mitochondrial H⁺-ATP synthase (ß-F1-ATPase) is a hallmark of most human carcinomas. This characteristic of the cancer cell provides a proteomic signature of cellular bioenergetics that can predict the prognosis of colon, lung, and breast cancer patients. Here we show that the in vivo tumor glucose uptake of lung carcinomas, as assessed by positron emission tomography in 110 patients using 2-deoxy-2-[¹⁸F]fluoro-D-glucose as probe, inversely correlates with the bioenergetic signature determined by immunohistochemical analysis in tumor surgical specimens. Further, we show that inhibition of the activity of oxidative phosphorylation by incubation of cancer cells with oligomycin triggers a rapid increase in their rates of aerobic glycolysis. Moreover, we show that the cellular expression level of the ß-F1-ATPase protein of mitochondrial oxidative phosphorylation inversely correlates (P < 0.001) with the rates of aerobic glycolysis in cancer cells. The results highlight the relevance of the alteration of the bioenergetic function of mitochondria for glucose capture and consumption by aerobic glycolysis in carcinomas. [Cancer Res 2007;67(19):9013–7]

This article has been cited by other articles:

				H. C. Keun, J. Sidhu, D. Pchejetski, J. S. Lewis, H. Marconell, M. Patterson, S. R. Bloom, V. Amber, R. C. Coombes, and J. Stebbing Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy Clin. Cancer Res., November 1, 2009; 15(21): 6716 - 6723. [Abstract] [Full Text] [PDF]

				M. Shanmugam, S. K. McBrayer, J. Qian, K. Raikoff, M. J. Avram, S. Singhal, V. Gandhi, P. T. Schumacker, N. L. Krett, and S. T. Rosen Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine J. Biol. Chem., September 25, 2009; 284(39): 26816 - 26830. [Abstract] [Full Text] [PDF]

				M. A. Kiebish, X. Han, H. Cheng, J. H. Chuang, and T. N. Seyfried Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer J. Lipid Res., December 1, 2008; 49(12): 2545 - 2556. [Abstract] [Full Text] [PDF]

				A. D. Ortega, S. Sala, E. Espinosa, M. Gonzalez-Baron, and J. M. Cuezva HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence Carcinogenesis, November 1, 2008; 29(11): 2053 - 2061. [Abstract] [Full Text] [PDF]

				R. J. Gillies, I. Robey, and R. A. Gatenby Causes and Consequences of Increased Glucose Metabolism of Cancers J. Nucl. Med., June 1, 2008; 49(Suppl_2): 24S - 42S. [Abstract] [Full Text] [PDF]

				E. Fosslien Cancer Morphogenesis: Role of Mitochondrial Failure Ann. Clin. Lab. Sci., January 1, 2008; 38(4): 307 - 330. [Abstract] [Full Text] [PDF]